OmniPod¿, Insulin Management System (OUS) Catalog Number: 14810 Product Usage: The OmnniPod...
FDA Device Recall #Z-0394-2016 — Class I — November 2, 2015
Recall Summary
| Recall Number | Z-0394-2016 |
| Classification | Class I — Serious risk |
| Date Initiated | November 2, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Insulet Corporation |
| Location | Billerica, MA |
| Product Type | Devices |
| Quantity | 5,179.0 boxes |
Product Description
OmniPod¿, Insulin Management System (OUS) Catalog Number: 14810 Product Usage: The OmnniPod¿ Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin and for the quantitative measurement of glucose in fresh whole capillary blood (in vitro) from the finger.
Reason for Recall
Pod's needle mechanism fails to deploy or there is a delay in the deployment of the needle mechanism.
Distribution Pattern
Worldwide Distribution - US Nationwide and countries of Switzerland, Germany, and Israel.
Lot / Code Information
Lot Codes: L41908, L41910, F41935
Other Recalls from Insulet Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0132-2026 | Class II | The failure occurs if a user on the Omnipod 5 i... | Sep 11, 2025 |
| Z-2016-2025 | Class II | Omnipod 5 Automated Insulin Delivery System, iO... | May 23, 2025 |
| Z-0591-2024 | Class I | Omnipod 5 App (on compatible Android smartphone... | Nov 30, 2023 |
| Z-2618-2023 | Class II | Omnipod 5 Automated Insulin Delivery System | Feb 28, 2023 |
| Z-0423-2023 | Class II | Omnipod 5 Automated Insulin Delivery System Pr... | Nov 14, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.